Cannabinoid Derived Pharmaceutical Market Size and Revenue Impact Study 2026 to 2035

Report Id: 1042 Pages: 180 Last Updated: 05 March 2026 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

What is Cannabinoid Derived Pharmaceutical Market Size?

Global Cannabinoid Derived Pharmaceutical Market Size is valued at USD 15.08 Billion in 2025 and is predicted to reach USD 96.36 Billion by the year 2035 at an 20.5% CAGR during the forecast period for 2026 to 2035.

Cannabinoid Derived Pharmaceutical Market Size, Share & Trends Analysis Report By Product (Natural (Plant-derived), Synthetic Cannabinoid), By Molecule Type (Cannabinoid Receptor Type 1 (CB1), Cannabinoid Receptor Type 2 (CB2), Others), By Disease Indication, By Route Of Administration, By Application, By Formulation, By Cannabinoid  Type, By Region, And Segment Forecasts, 2026 to 2035

Cannabinoid Derived Pharmaceutical Market

Cannabinoid Derived Pharmaceutical Market Key Takeaways:

  • Cannabinoid Derived Pharmaceutical Market Size is valued at USD 15.08 Billion in 2025 and is predicted to reach USD 96.36 Billion by the year 2035 
  • Cannabinoid Derived Pharmaceutical Market  Size is predicted to witness a 20.8% CAGR during the forecast period for 2026 to 2035.
  • Cannabinoid Derived Pharmaceutical Market is segmented into Product, Molecule Type, Disease Indication,  cannabinoid type, formulation, Application, Source and Other.
  • North America region is leading the Cannabinoid Derived Pharmaceutical Market 

Cannabinoids are naturally occurring compounds derived from the Cannabis sativa plant. In recent years, Cannabinoids/medical marijuana have witnessed increased attention due to its growing therapeutic applications in human medicine. Cannabinoid’s active components are potentially effective in treating a variety of conditions, including chronic pain, cancer pain, depression, anxiety disorders, sleep disturbances, and neurological disorders. The recent upsurge in the use and acceptance of CBD can be principally attributed to the onset of cannabis legalization across the United States. Most recently, the passage of the 2018 Farm Bill, which legalized the cultivation of hemp – cannabis with less than 0.3 percent THC by weight.

The demand for cannabinoid extracts and isolates is expected to grow exponentially in the coming years, on account of the anticipated shift in consumer preferences for derivative cannabis product formats, and the applications for cannabinoids in pharmaceutical applications. The market is also driven by growing awareness about the therapeutic benefits paired with healing properties associated with cannabidiol (CBD). Moreover, cannabidiol (CBD) is widely used in several medical applications such as treatment of anxiety and depression, stress relief, diabetes prevention, mitigation of pain, alleviation of cancer symptoms, and acne reduction. The market is expected to show lucrative opportunities over the forecast period owing to the augmented adoption of CBD-based products for treating various medical conditions.

Competitive Landscape

Some Of The Key Players In The Cannabinoid Derived Pharmaceutical Market:

  • Arena Pharmaceuticals (Pfizer)
  • Cannabics Pharmaceuticals Inc.
  • Cara Therapeutics, Inc.
  • Cardiol Therapeutics
  • GW Pharmaceuticals (Jazz Pharmaceuticals)
  • InMed Pharmaceuticals
  • INSYS Therapeutics, Inc.
  • LaraPharm
  • MGC Pharmaceuticals, Ltd.
  • One World Cannabis
  • Orpheus Medica
  • Receptor Life Sciences
  • RespireRx Pharmaceuticals
  • Tetra Bio-Pharma
  • United cannabis Corporation
  • Zynerba Pharmaceuticals
  • Other Players

Market Segmentation

The global Cannabinoid Derived Pharmaceutical market is segmented on the basis of product, application, and region. Based on the products, the market is divided into Cannabinoid Receptor Type 1 (CB1), Cannabinoid Receptor Type 2 (CB2), and Others. On the basis of application type, the market is segmented into Alzheimer’s Disease, Autism, Cancer, Chronic Pain, Epilepsy, Migraine, Multiple Sclerosis, Schizophrenia, and Others. By Formulation segment the market is divided into Oils and Tinctures, Capsules and Tablets, Oral Sprays, Topicals, Others. The Cannabinoid Type category comprises Cannabidiol (CBD), Tetrahydrocannabinol (THC), Others. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.

Cannabinoid Derived Pharmaceutical Market

Cannabinoid Derived Pharmaceutical Market Report Scope :

Report Attribute Specifications
Market Size Value In 2025 USD 15.08 Billion 
Revenue Forecast In 2035 USD 96.36 Billion
Growth Rate CAGR CAGR of 20.5% from 2026 to 2035
Quantitative Units Representation of revenue in US$ Million and CAGR from 2026 to 2035
Historic Year 2022 to 2025
Forecast Year 2026-2035
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Product, By Molecule Type, By Disease Indication, by cannabinoid type, by formulation, By Application, By Source
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; Japan; Brazil; Mexico ; France; Italy; Spain; China; Japan; India; South Korea; South East Asia
Competitive Landscape Cara Therapeutics, Inc., Arena Pharmaceuticals, Cannabics Pharmaceuticals Inc., Echo Pharmaceuticals, GW Pharmaceuticals, InMed Pharmaceuticals, INSYS Therapeutics, Inc., LaraPharm, MGC Pharmaceuticals, Ltd., One World Cannabis, Orpheus Medica, Receptor Life Sciences, RespireRx Pharmaceuticals, Tetra Bio-Pharma, Cardiol Therapeutics, United cannabis Corporation, Zynerba Pharmaceuticals, and List of Other Prominent Players.
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.
 
 
 
 

Cannabinoid Derived Pharmaceutical Market Segmentation :

Cannabinoid Derived Pharmaceutical Market, by Products-

  •  Natural (Plant-Derived Cannabinoids)
    • Epidiolex
    • Sativex
    • Other Plant-Derived Pipeline Products
  •  B. Synthetic Cannabinoids
    • Marinol
    • Syndros
    • Cesamet
    • Other Synthetic Pipeline Products

Cannabinoid Derived Pharmaceutical Market

Cannabinoid Derived Pharmaceutical Market, by Molecule Type-

  • Cannabinoid Receptor Type 1
  • Cannabinoid Receptor Type 2
  • Dual / Non-Selective Receptor Modulators
  • Others

Cannabinoid Derived Pharmaceutical Market, by By Source / Origin-

  • Plant-Derived Cannabinoids             
  • Synthetic Cannabinoids       

Cannabinoid Derived Pharmaceutical Market, by Disease Indication-

  • Alzheimer's Disease
  • Autism
  • Cancer
  • Chronic Pain
  • Epilepsy
  • Migraine
  • Multiple Sclerosis
  • Schizophrenia
  • Others

Cannabinoid Derived Pharmaceutical Market, by Formulation-

  • Oral       
  • Topical 
  • Oral Sprays        
  • Inhalation / Vaporization              
  • Others

Cannabinoid Derived Pharmaceutical Market, by Cannabinoid Type-

  • CBD-Based Pharmaceuticals        
  • THC-Based Pharmaceuticals        
  • Synthetic Cannabinoids
  • Minor Cannabinoids & Derivatives
  • Cannabinoid Receptor Modulators / Analogues

Cannabinoid Derived Pharmaceutical Market, By Distribution Channel -

  • Hospital Pharmacies
  • Retail Pharmacies / Drug Stores     
  • Online Pharmacies / Specialty Distribution

Cannabinoid Derived Pharmaceutical Market, By Therapeutic Indication / Application-

  • Neurological Disorders  
  • Chronic Pain      
  • Oncology / Cancer Supportive Care          
  • Psychiatric & Behavioral Disorders           
  • Inflammatory & Autoimmune Diseases  

Cannabinoid Derived Pharmaceutical Market, by Region-

  • North America-
    • The US
    • Canada
  • Europe-
    • Germany
    • The UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific-
    • China
    • Japan
    • India
    • South Korea
    • South East Asia
    • Rest of Asia Pacific
  • Latin America-
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  •  Middle East & Africa-
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa
 

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Enter Details and Get your PDF Brochure

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
8701
Security Code field cannot be blank!

Frequently Asked Questions

Cara Therapeutics, Inc., Arena Pharmaceuticals, Cannabics Pharmaceuticals Inc., Echo Pharmaceuticals, GW Pharmaceuticals, InMed Pharmaceuticals, INSYS Therapeutics, Inc., LaraPharm, MGC Pharmaceuticals, Ltd., One World Cannabis, Orpheus Medica, Receptor Life Sciences, RespireRx Pharmaceuticals, Tetra Bio-Pharma, Cardiol Therapeutics, United cannabis Corporation, Zynerba Pharmaceuticals, and List of Other Prominent Players.

Cannabinoid Derived Pharmaceutical Market Size is valued at USD 15.08 Billion in 2025 and is predicted to reach USD 96.36 Billion by the year 2035

The Cannabinoid Derived Pharmaceutical Market is expected to grow at an 20.5% CAGR during the forecast period for 2026 to 2035

Cannabinoid Derived Pharmaceutical Market is segmented into Product, Molecule Type, Disease Indication, cannabinoid type, formulation, Application, Source and Other.

North American region is leading the Cannabinoid Derived Pharmaceutical market.
Send Me the Sample Report Enquiry Before Buying